(RTTNews) -  Amylin Pharmaceuticals Inc. (AMLN: News ) reported a net loss of $26.7 million or $0.19 per share for the third quarter, compared to a loss of $79.0 million or $0.58 per share in the prior year quarter.

Total revenues for the quarter declined to $211.2 million from $218.4 million in the previous year quarter.
Analysts polled by Thomson Reuters expected the company to report a loss of $0.29 per share on revenue of $219.00 million for the quarter. Analysts' estimates typically exclude special items.

Click here to receive FREE breaking news email alerts for Amylin Pharmaceuticals Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com